Picking out these backlinks will choose you from KP.org. Kaiser Permanente is not to blame for the content material or procedures of exterior websites. Learn more about url conditions and terms.

pentobarbital will decrease the level or result of ethotoin by impacting hepatic enzyme CYP2C9/ten metabolism. Use Warning/Keep an eye on.

pentobarbital will decrease the level or impact of nelfinavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.

pentobarbital will decrease the extent or result of bosentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Not known.

pentobarbital will decrease the extent or influence of ritonavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.

pentobarbital will lessen the level or influence of doxorubicin liposomal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.

pentobarbital will minimize the level or outcome of quetiapine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

pentobarbital will lower the level or outcome of lefamulin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Steer clear of coadministration of lefamulin with strong or moderate CYP3A inducers get more info Except if the reward outweighs pitfalls. Check for diminished efficacy.

pentobarbital will decrease the extent or influence of zolpidem by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unfamiliar.

pentobarbital will lower the level or result of nateglinide by affecting hepatic enzyme CYP2C9/ten metabolism. Use Caution/Watch.

pentobarbital will lower the extent or outcome of cinacalcet by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.

pentobarbital will decrease the level or impact of bexarotene by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.

pentobarbital will minimize the level or result of avanafil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. For patients with ED, monitor response very carefully on account of potential for diminished success.

Contraindicated (1)pentobarbital will reduce the extent or result of elbasvir/grazoprevir by impacting hepatic/intestinal enzyme CYP3A4 metabolism.